Strive Towards the Era of Metaverse: du UAE and Huawei Sign MoU on 5.5G Strategic Cooperation
2.3.2023 06:11:00 EET | Business Wire | Press release
At Mobile World Congress (MWC) Barcelona 2023, du, from Emirates Integrated Telecommunications Company (EITC) and Huawei signed a Memorandum of Understanding (MoU) on 5.5G strategic cooperation, marking a new phase of their long-standing partnership.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230301005895/en/
du UAE and Huawei signing MOU (Photo: Business Wire)
As one of the fastest-growing telecommunication operators in the UAE, du works closely with Huawei and has outstanding performance in 5G network experience and service development, capturing a large share of the Middle East market. Through this partnership, du and Huawei will strengthen cooperation in 5.5G innovation, including technological innovation, and E2E network evolution, to help du continuously enhance user experience and lead the UAE market in 5.5G development.
Saleem AlBlooshi, CTO of du UAE, Cao Ming, President of Huawei Wireless Network Product Line, CEO of Huawei UAE, Liu Jiawei, and other executives from both parties attended the signing ceremony.
According to the MoU, du and Huawei will collaborate on 5.5G in three aspects. For innovation, they will focus on key technologies, including ELAA-MM (Extremely Large Antenna Array Massive MIMO), Passive IoT, Virtual Large Carrier among others, and discuss E2E network evolution roadmap. In terms of application exploration, they will conduct research on new scenarios and identify potential applications based on local requirements, such as Metaverse, holographic meeting, XR. In ecosystem construction, they will work together with local and global industry partners to build a sound 5.5G ecosystem and promote multilateral business success.
Saleem AlBlooshi, CTO of du, said, “du is committed to working with industry leaders around the world to create new solutions that help us stay at the forefront of digital innovation. In line with the UAE's Metaverse strategy, our partnership with Huawei will enable du to achieve our goal of making 5.5G technology available for commercial use, and together we can create immersive XR experiences for users that are high-quality and reliable. Our goal is to create an ecosystem in which every aspect of life can benefit from the unique features that 5.5G technology has to offer, ranging from improved connectivity and faster speeds to full-scenario IoT and extensive coverage.”
Cao Ming, President of Huawei Wireless Network Product Line, said, "We're committed to provide innovative solutions based on user requirements. We will work with du on 5.5G innovation, explore and promote 5.5G technologies, and commercialize high-value use cases based on the local scenarios in UAE, to improve network experience and build a digital, intelligent world."
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005895/en/
Contact information
Xu Jing, Huawei Technologies Co., Ltd, xujing70@huawei.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction19.6.2026 17:53:00 EEST | Press release
Record Currency Management Ltd (RCM), subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce its participation in an innovative local currency bond transaction issued by the European Bank for Reconstruction and Development (EBRD), supporting the development of Mongolia's capital markets while providing institutional investors with access to attractive frontier market opportunities. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group managing USD 115 billion of assets on behalf of institutional clients worldwide. Record's client base comprises pension funds, foundations, sovereign institutions and other asset managers, with whom the Group has built long-standing relationships through its focus on bespoke investment and risk management solutions. Headquartered in London, Record has offices in Hamburg, Zurich, Zug, New York, and Hong Kong. The investment forms part of Record Financial Group's broad
Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 15:29:00 EEST | Press release
Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level
Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 09:00:00 EEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom